Index of Authors

A list of all persons who contribute to the sessions of this conference. Please select a letter below to list all persons with the corresponding surname. Select the presentation in the right-hand column to access session and presentation details.

 
List by Initial Letter: A  B  C  D  E  F  G   H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  Å  Ø  Č  Š 
List Options: Authors and Sessions · Authors and Presentations   |   Include Session Chairs
 
Author(s) Organization(s) Session
Ha, Tae YoulKorea Food Research Institute, Korea, Republic of (South Korea)Tea Break and poster session
Tea Break and poster session  Presenter
Haack, Tobias B.Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany, 72076;
Center for Rare Diseases, University of Tübingen, Tübingen, Germany, 72076
Poster session
Haapanen, OutiDepartment of Physics, University of Helsinki, FinlandSession 2.3: Modelling pathogenic mechanisms: OXPHOS, metabolic rewiring and tissue specificity
Habermann, BiancaInstitut de Biologie du Développement de Marseille (IBDM), CNRS, UMR7288, Aix-Marseille Université, Marseille, France.Poster session
Haferkamp, UndineFraunhofer Institute for Translational Medicine and Pharmacology ITMP, ScreeningPort, Hamburg, GermanyTea Break and poster session
Hage, RabihCentre Hospitalier National d’Ophtalmologie des Quinze Vingts, Paris, FranceSession 4.2: Therapy 2: clinical trials
Tea Break and poster session
Haimilahti, KimmoResearch Program for Stem Cells and Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland;
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Session 4.2: Therapy 2: clinical trials  Presenter
Tea Break and poster session
Haimilahti, KimmoSTEMM, Faculty of Medicine, University of Helsinki, 00290 Helsinki, FinlandTea Break and poster session
Haimilahti, KimmoUniversity of Helsinki, FinlandTea Break and poster session
Haimilahti, KimmoResearch Program for Stem Cells and Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland;
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Tea Break and poster session  Presenter
Hakkarainen, AnttiHUS Diagnostic Center, Radiology, Helsinki University and Helsinki University Hospital, Helsinki, FinlandSession 4.2: Therapy 2: clinical trials
Tea Break and poster session
Haller, Ronald GUniversity of Texas Southwestern Medical Center, United States of AmericaPoster session
Hämäläinen, Riikka HelenaUniversity of Eastern Finland, FinlandTea Break and poster session
Hamers, Ilse H.J.Department of Toxicogenomics, Maastricht University, Maastricht, The NetherlandsPoster session
Han, AlexanderInstitute of Molecular and Cell Biology, A*STAR Research Entities, Singapore 138673, SingaporeSession 5.1: Late breaking news session
Han, JinmingApplied Immunology and Immunotherapy, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska University Hospital, Stockholm 17176, SwedenTea Break and poster session
Handler, AlyssaStealth BioTherapeutics, Needham, MA, United States of AmericaTea Break and poster session
Hangas, AnuUniversity of Eastern Finland, FinlandTea Break and poster session
Tea Break and poster session  Presenter
Tea Break and poster session
Hanna, MichaelCentre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United KingdomSession 2.2: Clinical 1: from new genes to old and novel phenotypes
Tea Break and poster session
Hanna, Michael GDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UKPoster session
Session 3.4: Clinical 2: natural history, biomarkers and outcome measures
Hanna, Michael G.Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK;
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Hanna, Michael G.Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UKSession 3.4: Clinical 2: natural history, biomarkers and outcome measures
Hanna, Michael G.Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK;
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK
Tea Break and poster session
Hanna, Michael G.Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UKTea Break and poster session
Hanna, Michael G.UCL Queen Square Institute of Neurology, United Kingdom;
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK.;
Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK
Tea Break and poster session
Tea Break and poster session
Hanna, Michael G.Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UKTea Break and poster session
Hansen, FynnMax-Planck Institute of Biochemistry, Martinsried, GermanyTea Break and poster session
Hansen, JakobDepartment of Forensic Medicine, Aarhus University, Aarhus, DenmarkPoster session
Hansikova, HanaDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech RepublicPoster session  Presenter
Poster session
Hansikova, HanaFirst Faculty of Medicine, Charles University; and General University Hospital in PraguePoster session
Hansíková, HanaDepartment of Paediatrics and Inherited Metabolic Disorders, Charles University and General University Hospital in Prague, Prague, Czech RepublicPoster session
Hansikova, HanaDepartment of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in PraguePoster session
Hansíková, Hana1st Faculty of medicine, Charles University, Prague, Czech RepublicTea Break and poster session
Hanssen, EricIan Holmes Imaging Centre, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria, AustraliaPoster session
Hansson, Magnus J.Mitochondrial Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden;
Abliva AB, Lund, Sweden
Tea Break and poster session
Hansson, Magnus J.Lund University, SwedenTea Break and poster session
Harashima, HideyoshiFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, JapanTea Break and poster session
Tea Break and poster session
Tea Break and poster session
Harashima, HideyoshiFaculty of Engineering, Hokkaido University, Sapporo, JapanTea Break and poster session
Hardij, RianneDepartment of Toxicogenomics, Maastricht University, Maastricht, The NetherlandsPoster session
Hardy, GaelleLaboratoire de génétique moléculaire: maladies héréditaires et oncologie, Service de biochimie, biologie moléculaire et toxicologie environnementale, CHU Grenoble et des Alpes, Institut de biologie et pathologie, GrenobleTea Break and poster session
Hardy, Steven ANational Disease Registration Service, NHS Digital, Leeds, UKSession 3.4: Clinical 2: natural history, biomarkers and outcome measures
Harjuhaahto, SandraStem Cells and Metabolism Research Program, Faculty of Medicine, University of HelsinkiTea Break and poster session  Presenter
Harley, JasmineInstitute of Molecular and Cell Biology, A*STAR Research Entities, Singapore 138673, SingaporeSession 5.1: Late breaking news session  Presenter
Harrison, EmmaDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom (add-tr.mitoteam@nhs.net)Tea Break and poster session
Hartono, Stella RDepartment of Molecular and Cellular Biology, University of Califofnia, DavisTea Break and poster session
Hartopp, NaomiUniversity of Sheffield, Sheffield Institute for Translational Neuroscience, United KingdomPoster session  Presenter
Tea Break and poster session
Hasselholt, StineDepartment of Clinical Medicine, Aarhus University, Denmark;
Center of Functionally Integrative Neuroscience
Tea Break and poster session  Presenter
Hata, RyujiFujita Health University School of Medicine, JapanTea Break and poster session
Hathazi, DenisaDepartment of Clinical Neurosciences, University of Cambridge, United KingdomPoster session
Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment  Presenter
Hattersley, Andrew T.Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UKTea Break and poster session
Hattersly, Andrew TInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UKPoster session
Hazan‬‏, ‪ReutHebrew university, IsraelTea Break and poster session  Presenter
Heales, SimonNeurometabolic Unit, NHNN, University College London Hospitals;
Chemical Pathology Laboratory, Great Ormond Street Hospital for Children;
Great Ormond Street Institute of Child Health, University College London
Tea Break and poster session
Heales, Simon J. R.Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK;
Neurometabolic Unit, The National Hospital for Neurology and Neurosurgery, London, UK
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Heid, IrisUniversity of Regensburg, GermanyPoster session
Heidler, JulianInstitute for Cardiovascular Physiology, Goethe University Frankfurt, GermanyPoster session
Heidler, JulianaFunctional Proteomics Group, Institute for Cardiovascular Physiology, Goethe University Frankfurt, 60590, Frankfurt am Main, GermanyPoster session
Heiduschka, SonjaDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, Heinrich Heine Universi-ty, Düsseldorf, GermanyTea Break and poster session
Heiman, MyriamPicower Institute for Learning and Memory, MIT, Cambridge, MA, USA;
Department of Brain and Cognitive Sciences, MIT, Cambridge, MA, USA
Session 5.1: Late breaking news session
Heinrichs, MarleenDepartment of Cellular Biochemistry, University Medical Center Goettingen, Goettingen, Germany;
Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Goettingen, Goettingen, Germany
Tea Break and poster session  Presenter
Heluani Gahete, HayatAndalusian Centre for Developmental Biology (CABD). CSIC-Universidad Pablo de Olavide-Junta de Andalucía. Carretera de Utrera Km 1, 41013 Sevilla, Spain.;
Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide. Carretera de Utrera Km 1, 41013 Seville, Spain
Session 3.3: Metabolic stress responses in mitochondrial diseases and cancer
Hemel, Irene M.G.M.Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, The NetherlandsTea Break and poster session  Presenter
Hempel, MajaInstitute of Human Genetics, University Medical Center Eppendorf, Hamburg, Germany;
Current address: Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Hempfling, StefanInstitute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany;
Bavarian NMR Centre, Department of Bioscience, School of Natural Sciences, Technical University of Munich, 85747 Garching, Germany
Session 5.1: Late breaking news session
Tea Break and poster session
Henckel, Melissa MUniversity of Colorado/Rocky Mountain Regional VA Medical Center, United States of AmericaPoster session
Hendriks, SachaDepartment of Genetics, Translational Metabolic Laboratory, Radboudumc, Nijmegen, The Netherlands.Tea Break and poster session
Henke, Marie-ThérèseCharité-Universitätsmedizin Berlin, Department of Neuropediatrics, Berlin, GermanyPoster session
Tea Break and poster session  Presenter
Hennick, AdèleInstitut NeuroMyoGene, PGNM UMR5261, INSERM U1315, Université Claude Bernard Lyon I Faculté de médecine Rockefeller, Lyon 08 FrancePoster session
Henrion, DanielUMR CNRS 6015, INSERM U1083, MitoVasc Institute, CarMe Team, University of Angers, FranceTea Break and poster session
Hentschel, AndreasLeibniz Institute of Analytical Sciences, ISAS, Dortmund, GermanySession 5.1: Late breaking news session
Tea Break and poster session
Hentschel, JuliaInstitute of Human Genetics, University Hospital, Leipzig, GermanyPoster session
Herbert, MaryNewcastle University, United Kingdom;
Newcastle Fertility Centre
Session 4.3: Therapy 3: reproductive options and mtDNA editing  Presenter
Tea Break and poster session
Hernández, Ana SandraBiomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain;
BCNatal—Barcelona Centre for Maternal-Foetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS, University of Barcelona, 08036 Barcelona, Spain
Tea Break and poster session
Hernández-Camacho, Juan DiegoInstitut Pasteur, Mitochondrial Biology Group, CNRS UMR 3691, Université Paris Cité, Paris, France.Poster session  Presenter
Herrero Martín, Juan CruzDepartment of Molecular Biology, Centro de Biología Molecular "Severo Ochoa" (CBMSO-UAM-CSIC), Madrid, SpainPoster session
Herrero-Martínez, DiegoPrograma de Terapia Génica y Regulación de la Expresión Génica, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra - Pamplona (Spain);
Instituto de Investigación Sanitaria de Navarra, IdiSNA - Pamplona (Spain)
Tea Break and poster session
Hesp, Laura FBRadboud University Medical Center, The NetherlandsPoster session
Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment
Heyne, EstelleDepartment of Cardiothoracic Surgery, University Hospital of Friedrich-Schiller-University Jena, GermanyPoster session
Heyne, EstelleJena University Hospital, Friedrich-Schiller University of Jena, GermanyTea Break and poster session
Tea Break and poster session  Presenter
Hibino, MitsueFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan;
Faculty of Engineering, Hokkaido University, Sapporo, Japan
Tea Break and poster session
Tea Break and poster session  Presenter
Tea Break and poster session
Tea Break and poster session
Hidalgo, Juan ManuelUniversitat Autònoma de Barcelona, Institut de Neurociències, Bellaterra, SpainTea Break and poster session
Hidalgo Gutiérrez, AgustínPhysiology Department, Biomedical Research Center, University of Granada, Granada, SpainTea Break and poster session
Hidalgo-Gutierrez, AgustinDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, 10032, United StatesPoster session
Poster session
Session 2.2: Clinical 1: from new genes to old and novel phenotypes  Presenter
Hidalgo-Gutierrez, AgustinColumbia University Irving Medical Center, New York, USA, United States of AmericaSession 4.2: Therapy 2: clinical trials
Hidalgo-Gutiérrez, AgustínPhysiology Department, Biomedical Research Center, University of Granada, SpainTea Break and poster session
Hidalgo-Gutierrez, AgustinDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USATea Break and poster session  Presenter
Hietakangas, VilleHelsinki Institute of Life Science HiLIFE, University of Helsinki;
Faculty of Biological and Environmental Sciences, University of Helsinki
Tea Break and poster session
Higgins-Chen, AlbertYale University, United States of AmericaPoster session
Hikage, YugaNational Defense Academy, JapanPoster session
Hikmat, OmarDepartment of Paediatrics and Adolescent Medicine, Haukeland University Hospital, Norway;
Department of Clinical Medicine (K1), University of Bergen, Norway;
Department of Pediatrics, Haukeland University Hospital, Norway
Session 3.4: Clinical 2: natural history, biomarkers and outcome measures  Presenter
Tea Break and poster session
Tea Break and poster session
Hilander, TaruGenetics Section, Molecular and Clinical Sciences, St George’s, University of London, London, United KingdomTea Break and poster session
Hillen, HaukeDepartment of Cellular Biochemistry, University Medical Center Göttingen, Germany;
Research Group Structure and Function of Molecular Machines, Max-Planck-Institute for Multidisciplinary Sciences Göttingen, Germany;
Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Goettingen, Goettingen, Germany;
Cluster of Excellence (MBExC), University of Göttingen, Germany
Session 2.4: New technological developments and OMICS  Presenter
Tea Break and poster session
Tea Break and poster session
Hiltunen, J KalervoFaculty of Biochemistry and Molecular Medicine, University of Oulu, FinlandTea Break and poster session
Hiltunen, J. KalervoFaculty of Biochemistry and Molecular Medicine, University of Oulu, FinlandPoster session
Hines, DeclanDepartment of Clinical Neurosciences, University of Cambridge, United KingdomTea Break and poster session
Hink, Mark AUniversity of Amsterdam, The NetherlandsPoster session
Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment
Hirano, M.H. Houston Merritt Neuromuscular Research Center, Department of Neurology, Columbia University Irving Medical Center, New York, NY, USATea Break and poster session
Hirano, MichioColumbia University Irving Medical Center, United States of AmericaPoster session
Hirano, MichioDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USASession 2.2: Clinical 1: from new genes to old and novel phenotypes
Hirano, MichioColumbia University Irving Medical Center, United States of AmericaSession 3.4: Clinical 2: natural history, biomarkers and outcome measures
Session 4.2: Therapy 2: clinical trials  Presenter
Hirano, MichioDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USATea Break and poster session
Hirano, MichioColumbia University Irving Medical Center, United States of AmericaTea Break and poster session
Hiz, SemraIzmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Izmir, TurkeySession 2.2: Clinical 1: from new genes to old and novel phenotypes
Hnízda, AlešDepartment of Paediatrics and Inherited Metabolic Disorders, Charles University and General University Hospital in Prague, Prague, Czech RepublicPoster session
Ho, LenaDuke-NUS Medical School, SingaporePoster session  Presenter
Session 2.3: Modelling pathogenic mechanisms: OXPHOS, metabolic rewiring and tissue specificity  Presenter
Hoberg, EmilyDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, P.O. Box 440, SE-405 30 Gothenburg, SwedenTea Break and poster session
Hock, DaniellaDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.Poster session
Hock, DaniellaDepartment of Biochemistry and Pharmacology, University of Melbourne, Melbourne, AustraliaTea Break and poster session
Hock, DaniellaUniversity of Melbourne, Parkville, AustraliaTea Break and poster session
Hock, DaniellaUniversity of Melbourne, Melbourne, AustraliaTea Break and poster session
Hock, Daniella HUniversity of Melbourne, Parkville, AustraliaTea Break and poster session  Presenter
Hodgkinson, AlanDepartment of Medical and Molecular Genetics, School of Basic and Medical Biosciences, King’s College London, London, United KingdomPoster session  Presenter
Hodsdon, PhilipOxford Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, UK;
NHS Highly Specialised Services for Rare Mitochondrial Disorders, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Tea Break and poster session
Tea Break and poster session
Hoeijmakers, Janneke G.J.School for Mental Health and Neurosciences (MHeNS), Maastricht University Medical Centre+, Maastricht, The Netherlands;
Department of Neurology, Maastricht University Medical Centre+, Maastricht, The Netherlands
Session 4.2: Therapy 2: clinical trials
Hohorst, LisaCECAD, GermanyTea Break and poster session
Hoitzing, HanneDepartment of Mathematics, Imperial College London, United KingdomTea Break and poster session
Holm, ChristianDepartment of Biomedicine, Aarhus Research Center for Innate Immunology, Aarhus University, Aarhus, DenmarkSession 3.1: Inflammation and Immunity as mitochondrial contributor to pathology
Tea Break and poster session
Holmes, Holly E.Elysium Health New York, New York, NY 10013, USATea Break and poster session
Honzik, TomasDepartment of Pediatrics and Inherited Metabolic Disorders, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech RepublicPoster session
Poster session
Honzík, Tomáš1st Faculty of medicine, Charles University, Prague, Czech RepublicTea Break and poster session
Hool, LiviaSchool of Human Sciences (Physiology), The University of Western Australia, Crawley, Western Australia 6009, Australia.;
Victor Chang Cardiac Research Institute, Darlinghurst, Sydney, New South Wales 2010, Australia.
Tea Break and poster session
Hopton, SilaWellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK;
NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK
Session 2.1: mtDNA maintenance and expression
Tea Break and poster session
Horton, Rachel L.Centre for Personalised Medicine, and Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK;
Clinical Ethics, Law and Society, Faculty of Medicine, University of Southampton, Southampton, UK
Tea Break and poster session
Horvath, RitaDepartment of Clinical Neurosciences, University of Cambridge, United KingdomPoster session
Horvath, RitaDepartment of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge, UK.Poster session
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Horvath, RitaCambridge-UK, United KingdomSession 2.2: Clinical 1: from new genes to old and novel phenotypes  Presenter
Session 3.2: Mitochondrial mechanisms in neurodegeneration and neurodevelopment
Horvath, RitaDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKSession 3.4: Clinical 2: natural history, biomarkers and outcome measures
Session 3.4: Clinical 2: natural history, biomarkers and outcome measures
Horvath, RitaDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom (add-tr.mitoteam@nhs.net)Tea Break and poster session
Tea Break and poster session
Horvath, SteveAltos labs, United States of AmericaPoster session
Houghton, DavidNational Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;
Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, UK
Session 3.4: Clinical 2: natural history, biomarkers and outcome measures
Houghton, DavidWellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute; NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne NE2 4HH, UKTea Break and poster session
Houghton, DavidNational Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;
Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, UK
Tea Break and poster session
Houlden, HenryDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UKSession 2.2: Clinical 1: from new genes to old and novel phenotypes
Session 2.2: Clinical 1: from new genes to old and novel phenotypes
Houštěk, JosefInstitute of Physiology of the Czech Academy of Sciences, Czech RepublicPoster session
Houštěk, JosefDepartment of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Prague, Czech RepublicPoster session
Houštěk, JosefInstitute of Physiology of the Czech Acad. Sci., Prague, Czech RepublicPoster session
Houštěk, JosefLaboratory of Bioenergetics, Institute of Physiology, Czech Academy of Sciences, Prague, Czech RepublicPoster session
Tea Break and poster session
Tea Break and poster session
Houtkooper, RiekeltLaboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsSession 3.1: Inflammation and Immunity as mitochondrial contributor to pathology
Tea Break and poster session
Howting, DeniseHarry Perkins Institute of Medical Research, Perth, AustraliaTea Break and poster session
Høyer, HelleDepartment of Medical Genetics, Telemark Hospital Trust, Skien, NorwayTea Break and poster session
Hrabě de Angelis, MartinInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Center Munich, German Research Center for Environmental Health, Germany;
Member of German Center for Diabetes Research (DZD), Germany;
Chair of Experimental Genetics Experimental Genetics, School of Life Science Weihenstephan, Technische Universität München, Germany;
Contributed equally
Tea Break and poster session
Hsieh, Yu-HsinBerlin Institute of Health at Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany;
Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), 10115 Berlin, Germany
Session 2.4: New technological developments and OMICS
Hu, BowenStem Cells and Metabolism Research Program, Faculty of Medicine, University of HelsinkiTea Break and poster session
Huang, Cheng-KaiInstitute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, GermanyTea Break and poster session
Huang, SidongMcGill University, CanadaTea Break and poster session
Huang, Yu-WenMackay Memorial Hospital, TaiwanTea Break and poster session  Presenter
Huber, NicoleMedical University of Innsbruck, 6020 Innsbruck, AustriaSession 1.1: The impact of mtDNA variation and environment on rare and common diseases
Hudson, GavinUniversity of Newcastle, Newcastle upon Tyne, UKPoster session
Hudson, Gavin H.Wellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, Newcastle University, Newcastle upon Tyne, UKTea Break and poster session
Hughes, LaetitiaHarry Perkins Institute of Medical Research, Nedlands, Western Australia 6009, Australia;
ARC Centre of Excellence in Synthetic Biology, QEII Medical Centre, Nedlands, Western Australia 6009, Australia;
Centre for Medical Research, The University of Western Australia, QEII Medical Centre, Nedlands, Western Australia 6009, Australia.
Tea Break and poster session
Hughes, RachelUniversity of Sheffield, Sheffield Institute for Translational Neuroscience, United KingdomPoster session
Hughes, Rachel MSheffield Institute for Translational Neuroscience, University of Sheffield, United KingdomTea Break and poster session  Presenter
Human, RonelDepartment of Paediatrics, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South AfricaSession 2.2: Clinical 1: from new genes to old and novel phenotypes
Tea Break and poster session
Hunter, HeatherThe Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UKSession 3.4: Clinical 2: natural history, biomarkers and outcome measures
Tea Break and poster session
Tea Break and poster session
Hunter, MatthewMonash Genetics, Monash Health, Melbourne, Australia;
Department of Paediatrics, Monash University, Melbourne, Australia
Tea Break and poster session
Hurd, Thomas RDepartment of Molecular Genetics, University of Toronto, Toronto, CanadaTea Break and poster session
Hyslop, LouiseNewcastle Fertility CentreSession 4.3: Therapy 3: reproductive options and mtDNA editing